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An understanding of the regulatory mechanisms responsible for pluripotency in embryonic stem cells (ESCs) is critical for realizing their
potential in medicine and science. Significant similarities exist among ESCs harvested from different species, yet major differences have also been
observed. Here, by cross-species analysis of a large set of functional categories and all transcription factors and growth factors, we reveal
conserved and divergent functional landscapes underlining fundamental and species-specific mechanisms that regulate ESC development. Global
transcriptional trends derived from all expressed genes, instead of differentially expressed genes alone, were examined, allowing for a higher
discriminating power in the functional portrait. We demonstrate that cross-species correlation of transcriptional changes that occur upon ESC
differentiation is a powerful predictor of ESC-important biological pathways and functional cores within a pathway. Hundreds of functional
modules, as defined by Gene Ontology, were associated with conserved expression patterns but bear no overt relationship to ESC development,
suggestive of new mechanisms critical to ESC pluripotency. Yet other functional modules were not conserved; instead, they were significantly up-
regulated in ESCs of either species, suggestive of species-specific regulation. The comparisons of ESCs across species and between human ESCs
and embryonal carcinoma stem cells suggest that while pluripotency as an essential function in multicellular organisms is conserved throughout
evolution, mechanisms primed for differentiation are less conserved and contribute substantially to the differences among stem cells derived from
different tissues or species. Our findings establish a basis for defining the “stemness” properties of ESCs from the perspective of functional
conservation and variation. The data and analyses resulting from this study provide a framework for new hypotheses and research directions and a
public resource for functional genomics of ESCs.
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Embryonic stem cells (ESCs) are pluripotent cells with
indefinite replication potential and the ability to differentiate
into all types of cells. As demonstrated in various in vitro
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doi:10.1016/j.ygeno.2006.09.010science [1–5]. Understanding the regulatory mechanism
responsible for pluripotency in ESCs is of central importance
toward realizing their therapeutic and scientific potential.
Previous investigations examining differentially expressed
genes during ESC differentiation have begun to elucidate the
pathways and networks controlling ESC self-renewal and
differentiation [6–9]. However, gene expression analyses
focused primarily on fold changes often overlook relatively
low, yet concerted changes in expression levels of genes; these
changes in coordinated gene expression, despite being subtle,
may dramatically alter the flux of pathways and their overall
active or inactive states [10–12]. Moreover, functional profiling
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small number of functional modules that the genes are
associated with. A global trend analysis of gene expression by
employing all expressed genes allows for a greater discrimina-
tive power in functional profiling, even when the transcriptional
changes on individual genes are rather small [10–13]. However,
no large-scale functional profiling has been conducted on ESCs
with global patterns of gene expression.
The first ESC line was derived from the inner cell mass (ICM)
of preimplantation mouse embryos [14,15]. Since then, ESCs
have been isolated from various organisms, including human
[16–18]. While significant similarities exist among ESCs
harvested from different species, major differences have also
been reported [19–21]. Important biological processes or
pathways, like important sequence elements in the genome,
are often evolutionarily conserved [19,22,23]. Comparative
transcriptomics analysis has been successful in identifying
functional modules conserved through evolution [10,22,24].
The observed conservation and variation among ESCs suggest
that cross-species gene expression analysis and functional
profiling may help distinguish between fundamental and
species-specific mechanisms controlling ESC development
and define the core “stemness” properties.
In this study, we employed a global gene expression analysis
for a large-scale cross-species functional profiling of ESCs. We
systematically surveyed all biological processes, molecular
functions, and cellular components determined by Gene
Ontology (GO); pathways defined by the Kyoto Encyclopedia
of Genes and Genomes (KEGG); and transcription factors and
growth factors. In each functional module, we examined all
expressed genes, instead of differentially expressed genes alone,
to explore not only major but also subtle yet important
transcriptional changes that occur upon ESC differentiation.
Evolutionarily conserved and divergent functional modules
were identified from human and mouse ESCs. The conserved
modules, showing positive cross-species correlation of the
expression pattern, represent core biological networks or
mechanisms fundamental to ESC development. The divergent
modules, showing negative or no correlation in expression
pattern, are suggestive of species-specific regulation in ESCs.
The cross-species correlation of expression pattern is a powerful
predictor of ESC-important biological pathways and functional
cores within a pathway. Hundreds of functional modules, as
defined by GO, were associated with conserved expression
patterns but bear no overt relationship to ESC development,
suggestive of newmechanisms critical to ESC pluripotency. The
comparisons of ESCs across species and between human ESCs
and embryonal carcinoma stem cells (ECCs) suggest that while
pluripotency as an essential function in multicellular organisms
is conserved throughout evolution, mechanisms primed for
differentiation are less conserved and contribute substantially to
the differences among stem cells derived from different tissues
or species. The study establishes a basis to define the “stemness”
properties by conserved and divergent functional landscapes of
ESCs. The data and analyses resulting from this study provide a
framework for new hypotheses and research directions and a
public resource for functional genomics of ESCs.Results
We determined gene expression profiles of multiple
human embryonic stem cell (hESC) lines and their
differentiated cell counterparts, embryoid bodies (EBs),
using Illumina BeadArray. Supplementary Fig. S1 shows
the cultured hESC and hEB cells. The array contained
23,584 probes, representing 20,692 unique genes. We
obtained the mouse embryonic stem cell (mESC) dataset
from the GEO database (GSE2375). The mESC dataset
contained expression profiles of the R1 cell line and
differentiated EB counterpart. From the hESC and mESC
datasets, we selected 5459 human–mouse orthologous gene
pairs that show significant signal levels for our analyses. The
hESC samples had correlation coefficient values greater than
0.96 with each other, while the hEB samples had pair-wise
correlation values greater than 0.92. The mESC and mEB
samples had correlations greater than 0.99 and 0.93,
respectively. Many differentially expressed genes have been
identified in ESCs and found to be important to self-renewal
or differentiation [7,8,13,30–34]. However, small or subtle
changes in expression can sometimes dramatically alter the
flux of pathways and their overall active or inactive states
[10–12]. A less than twofold increase in Oct3/4, for
example, can lead to differentiation of mouse ESCs to
primitive endoderm and mesoderm, while a repression of
Oct3/4 results in loss of pluripotency and differentiation to
trophectoderm [35]. It is important to capture such relatively
small yet significant expressional changes, which are,
however, often overlooked by analysis focusing primarily
on fold changes. In this study, we addressed this problem by
including all expressed genes, regardless of their relative
levels of changes, and analyzing the global trend in
expression pattern across different functional sets in human
and mouse. First, we summarized the expression change of a
given gene i as the ratio of average expression levels before
and after differentiation (represented by xi). For a functional
module with n genes (e.g., 84 genes of the Wnt pathway),
the expression pattern of the module is represented as a
vector of relative changes in expression across the n genes
(represented by x=[x1, x2, …, xn]). We then assessed the
evolutionary conservation of the functional module in
expression pattern based on the human–mouse orthologous
gene pairs by calculating the Pearson correlation (r) between
the vectors xh (expression profile vector in human) and xm
(expression profile vector in mouse). The significance level
of the observed correlation, measured by the p value, is
dependent on both the correlation value (r) and the group
size (n). Therefore, a large group of genes with a relatively
low correlation in expression pattern could still be
significant, and the method would thus help reveal subtle
or hidden changes and a global trend of conservation.
Our results showed that the global cross-species correlation
in expression pattern over all expressed genes was 0.301. The
correlation was highly significant statistically (p<10−114). This
indicates that despite profound differences between hESCs and
mESCs, a certain number of orthologous genes behave similarly
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conducted a systematic survey across all functional modules
defined by the GO and KEGG databases and examined all
transcription factors and growth factors to identify the
categories that contributed significantly to the observed global
conservation of expression patterns across species. Three
different types of functional modules were identified through
the survey: (1) the expression patterns were positively
correlated between human and mouse ESCs (p<0.05); (2) the
expression patterns were not correlated (p≥0.05); and (3) the
expression patterns were negatively correlated (r<0, p<0.05).
The functional modules of the first type were considered to be
evolutionarily conserved, while those in the second and third
types were evolutionarily divergent. The results are summarized
in Table 1 and details are provided in Supplementary Tables S1
and S2. Of the 903 GO-defined biological processes with which
all human&ndash;mouse orthologous genes from our datasets
were associated, 43.1% (i.e., 389 biological processes) were
evolutionarily conserved (p<0.05) (Table 1; Supplementary
Table S1a). The other 56.9% (514 processes) were evolutiona-
rily divergent, showing either a negative (0.07%) or no (56.2%)
cross-species correlation. The GO-defined molecular function
and cellular component exhibited a similar distribution of
conserved and divergent groups (Table 1; Supplementary Tables
S1b and S1c). Among all KEGG-defined pathways with which
the human–mouse orthologous genes were associated, 14
showed a positively correlated expression pattern, 3 showed a
negative correlation, while the remaining 88 showed a
noncorrelated expression pattern (Table 1; Supplementary
Table S2). Fig. 1 depicts expression patterns of some conserved
and divergent functional modules that are important to ESC
development. As shown by the heat maps in the figure, each
column represents an orthologous gene expressed in hESCs (top
row) and mESCs (bottom row). The expression fold change of a
gene is represented by different colors (green, down-regulated
in ESCs; red, up-regulated in ESCs; black, no change between
ESCs and EBs). The conserved modules (Fig. 1A) were
associated with high correlation values (r), by which many
orthologous genes showed expression in the same direction
(e.g., either up-regulated in both species or down-regulated in
both) with similar expression fold changes in human andTable 1
Number of functional modules showing positive, negative, or no correlation for th
(p<0.05)
Cross-species transcriptional
correlation
Gene group Biolog
proces
Positively correlated Total 389
Up-regulated in hESCs 105
Down-regulated in hESCs 54
Up-regulated in mESCs 157
Down-regulated in mESCs 110
Not correlated Total 508
Up-regulated in hESCs 135
Down-regulated in hESCs 113
Up-regulated in mESCs 265
Down-regulated in mESCs 333
Negatively correlated Total 6mouse. The divergent modules (Fig. 1B) were associated with
low or negative correlation values (r), by which most
orthologous genes showed expression in opposite directions
(e.g., up-regulated in one species and down-regulated in the
other) with dissimilar expression fold changes between human
and mouse. Detailed information for each module in Fig. 1 is
provided in Supplementary Table S3.
Conserved functional modules
All conserved functional modules identified in this study are
listed in Supplementary Table S1 for GO categories and
Supplementary Table S2 for KEGG pathways (denoted by [E]
on the term names). The conserved biological processes (GO)
were classified into several major categories, shown by the pie
chart in Fig. 2. As illustrated, 13.8% of the conserved biological
processes were involved in development, such as cellular
morphogenesis (97 orthologous genes, r=0.325, p<0.001),
embryonic development (87 orthologs, r=0.318, p<0.005),
pattern specification (50 orthologs, r=0.57, p<10−5), and
determination of left/right symmetry (6 orthologs, r=0.79,
p<0.05) (Fig. 2). The conserved functional modules also inclu-
ded establishment and/or maintenance of chromatin architecture
(1% of all conserved processes, including chromosome
remodeling; 67 orthologs, r=0.505, p<10−5), responses to
stimuli (7.2%, including response to damaged DNA and
unfolded proteins), cell proliferation and cell cycle (6.2%),
signal transduction (4.1%), apoptosis (1.8%), and metabolism
(44.1%, including DNA replication and packaging) (Fig. 2).
Fourteen pathways defined by KEGG were conserved
(Supplementary Table S2), including TGF-β (52 orthologs,
r=0.411, p<0.005), Wnt (84 orthologs, r=0.236, p<0.05),
Nodal (8 orthologs, r=0.695, p<0.05), and integrin-mediated
signaling pathways (18 orthologs, r=0.427, p<0.05). These
andmany other conserved biological process and pathways have
been considered to be important for ESC development [36–39].
The conserved biological processes and pathways identified in
our study, together with transcriptionally conserved transcrip-
tion factors and growth factors (described below), represent core
biological networks and mechanisms that are fundamental for
ESC self-renewal and differentiation in different species. Fig. 1Ae transcriptional changes upon ESC differentiation between human and mouse
ical
s (GO)
Molecular
function (GO)
Cellular
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154 102 14
31 20 2
21 16 5
63 43 4
43 23 2
258 121 88
67 28 4
85 39 10
129 84 8
138 47 5
1 2 3
Fig. 1. Expression patterns of selected (A) converged and (B) divergent biological processes and pathways. On the heat map of each module, the column represents an
orthologous gene expressed in hESC (top row) and in mESC (bottom row). The expression fold change of the gene is represented by different colors (green, down-
regulated in ESC; red, up-regulated in ESC; black, no change). For conserved modules (A; with high r values), many orthologous genes showed expression in the same
direction (i.e., either up-regulated in both species or down-regulation in both) with similar expression fold changes between human and mouse. For divergent modules
(B; low or negative r values), most orthologous genes showed expression in opposite directions (i.e., up-regulated in one species and down-regulated in the other) with
dissimilar expression fold changes between human and mouse. Details of the genes shown in each module along with the expression values and fold changes are
provided in Supplementary Table S3. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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modules important for ESC development (detailed information
for each module in the figure is given in Supplementary Table
S3). Table 2A shows conserved signal transduction pathways
and their expression in ESCs and EBs of human and mouse.
Because of rapid DNA replication and the absence of cell-
cycle checkpoints, ESCs require extra mechanisms more
sensitive than those of somatic cells to ensure genomic stability
and to prevent transmission of mutations to offspring cells [40].This may be achieved by active repression of spontaneous
mutations, as well as removal of damaged cells by apoptosis.
We found that genes involved in the response to DNA-
damaging stimuli and DNA repair had relatively low, yet
significant cross-species correlation in their expression patterns
(r=0.261 and 0.269, respectively; p<0.01 in both) (Fig. 1),
supporting the hypothesis that their evolutionary conservation is
of fundamental importance to ESC self-renewal. In particular,
the genes MLH1, MSH2, MSH3, MSH5, PMS2, and POLD3,
Fig. 2. Summary of conserved biological processes showing correlated expression patterns between human and mouse ESCs.
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highly conserved (r=0.912, p<0.01) and thus comprised the
core functional elements in DNA repair processes of ESCs.
Apoptosis showed a low but highly significant cross-species
correlation in expression pattern (198 orthologs r=0.313,
p<10−5) (Fig. 1). Moreover, genes involved in the response to
unfolded proteins and telomere maintenance showed high levels
of conservation (r=0.413 and 0.802, respectively; p<0.01 in
both). The results suggest that these biological processes
critically contribute to ensuring rapid yet accurate DNA
replication and chromosome integrity during ESC self-renewal.
Cell-cycle control mechanisms in ES cells differ from those
in somatic cells [41]. ES cells are primed for rapid cell
proliferation. Both rodent and monkey ES cells achieve this by
shortening the G1 phase and bypassing DNA damage G1
checkpoints [41]. Our examination of 304 human–mouse
orthologous genes involved in cell-cycle progression showed aTable 2
Transcriptionally (A) conserved and (B) diverged signal transduction pathways
Pathway Correlation (r) Ortho
(A) Conserved
TGF-β signaling 0.41 52
Wnt signaling 0.24 84
Notch signaling 0.45 23
Nodal signaling 0.7 8
ECM–receptor interaction 0.29 43
Integrin-mediated signaling 0.43 18
(B) Diverged
Cytokine–cytokine receptor interaction –0.31 69
Phosphatidylinositol signaling system 0.19 39
JAK–Stat signaling 0.14 53
Toll-like receptor signaling 0.14 38
Hedgehog signaling 0.17 25
FGF signaling –0.17 19
LIF signaling –0.26 16
Insulin signaling 0.06 73
MAPK signaling 0.03 128
Calcium signaling –0.01 75
Neuroactive ligand–receptor interaction –0.01 58
a LIF pathway was down-regulated in BG01, BG01V, and BG02, but did not chasignificantly conserved expression pattern (r=0.486, p<10−18).
In particular, 18 genes involved in the G1/S transition of the
mitotic cell cycle and 17 genes involved in cell-cycle arrest were
highly conserved (r=0.623 with p<0.005, r=0.573 with
p<0.01, respectively). Moreover, 171 additional genes involved
in regulation of the cell cycle were also significantly conserved
(r=0.51, p<10−12) (Fig. 1). The results suggest that these
biological processes are fundamentally important to ESC self-
renewal of different species.
The Nodal pathway is implicated in early patterning of the
embryo, left–right axis specification, and ESC development [42–
45]. The pathway was highly conserved (r=0.695, p<0.05) (Fig.
1; Supplementary Table S3). Among the eight human–mouse
orthologous genes examined for this pathway, while SMAD2 and
SMAD3 did not show significant transcriptional changes in either
hESCs or mESCs, LEFTB and TDGF1 exhibited at least twofold
up-regulation in both hESCs and mESCs. The coordinated up-log pairs p value Transcription change
hESC mESC
0.001 Down Up and down
0.015 Up and down Down
0.016 Down None
0.028 Up Up
0.029 Down Down
0.039 Down Down
0.005 Down None
0.123 Down None
0.157 Down None
0.198 Down None
0.204 Down Down
0.24 None Up
0.169 Down a None
0.31 Down Up
0.355 Down None
0.448 Down None
0.472 Down Down
nge in BG03.
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frequency analysis [7]. LEFTB is an antagonist and TDGF1 acts as
a coreceptor for Nodal in Nodal signaling. The conserved
expression pattern, especially for the coactivators of Nodal,
TDGF1, and LEFTB, indicates that the Nodal pathway is
fundamental to ESC pluripotency in different species.
The Wnt pathway is active in determining the fate of stem
cells and in self-renewal [46–49]. The pathway exhibited a low
yet significant level of cross-species correlation in expression
pattern (r=0.236, p<0.05) (Fig. 1; Supplementary Table S3).
Nineteen of the 84 orthologous genes examined for this
pathway showed at least 1.5-fold expression change upon
ESC differentiation in both species. Among the 19 genes, 15
showed up- and down-regulation in the same direction. The 15
conserved genes included Wnt family members (WNT1,
WNT2B, and WNT5B), frizzled receptors (FZD2, FZD6, and
FZD8), the antagonist DKK1, and downstream members of the
pathway (FRAT2, CTBP2, TP53, MYC, DVL3, RAC2,
CCND2, and CCND3). The Wnt family members and frizzled
receptors, as well as DKK1, FRAT2, CTBP2, DVL3, RAC2,
CCND2, and CCND3, were down-regulated in both hESCs and
mESCs, while TP53 and MYC were up-regulated in ESCs. The
observed evolutionary conservation of expression pattern
suggests that Wnt signaling plays a fundamental role in
maintaining ES cell pluripotency. However, it is important to
note that 4 genes of the pathway showed transcriptional changes
over 1.5-fold in opposite directions between hESCs and
mESCs: CSNK2A2 (down-regulated in hESCs but up-regulated
in mESCs) and FZD9, SFRP1, and PRKCB1 (up-regulated in
hESCs but down-regulated in mESCs). These genes represented
divergent peaks in the overall conserved landscape of this
pathway. This divergence may explain the differing results of
the effects of Wnt on hESC self-renewal [50].
The BMP/TGF-β pathway is involved in regulating cell
proliferation and differentiation, mesoderm formation and
patterning, and ESC development [51–55]. The pathway
showed a significant level of positive correlation in expression
pattern between hESCs and mESCs (r=0.411, p<0.005) (Fig.
1; Supplementary Table S3). Eight of the 52 orthologous genes
examined for this pathway showed at least 1.5-fold expression
change upon ESC differentiation, by which BMP4, BMP5,
MADH6, ID2, and PITX2 were down-regulated in both human
and mouse, while THBS2, MYC, and GDF3 were up-regulated
in both species. This conserved expression pattern of ligands,
intermediate signal transducers, and target genes suggests that
BMP/TGF-β signaling is fundamentally important for ESC
self-renewal and differentiation. However, there were 5 genes
showing divergent expression patterns: INHBA, MADH7,
THBS1, and MAPK1 were up-regulated in mESCs but down-
regulated in hESCs; INHBE was down-regulated in mESCs
but up-regulated in hESCs. The pathway therefore presents a
mosaic structure with conserved functional cores and divergent
domains, similar to the Wnt pathway. This is consistent with
recent reports that BMP supports mESC self-renewal but
activin appears to do so in hESCs [56,57].
The Notch pathway helps to determine cell fate through cell–
cell interactions [58] and is reportedly involved in hESC self-renewal [59]. Overall, the pathway showed a conserved expression
pattern across species (r=0.451, p<0.05) (Fig. 1; Supplementary
Table S3). However, 12 of the 23 orthologous genes examined for
this pathway showed less than 1.5-fold expression change upon
ESC differentiation in both human and mouse, which included
the receptors NOTCH1 and NOTCH4 and the ligands DVL2 and
JAG2. Only 3 genes exhibited more than 1.5-fold expression
change in both human and mouse and positively correlated
expression pattern: DVL3 (down-regulated in ESCs) and
RBPSUH and CTBP2 (both up-regulated in ESCs). The subtle
yet conserved expression pattern seems important for this
pathway’s role in ESC self-renewal. The cross-species analysis
is effective in exploring such moderate, though conserved,
transcriptional changes for functional understanding.
Integrins mediate cell adhesion to the extracellular matrix,
control cell cycle progression, regulate WNT1 and BMP4
expression, and activate the mesodermal and neuroectodermal
lineage for ESC differentiation [60,61]. We examined 18 human
and mouse orthologous genes involved in the integrin-mediated
signaling pathway. The pathway was conserved in transcrip-
tional changes during ESC differentiation (r=0.427, p<0.05)
(Fig. 1; Supplementary Table S3). The transcriptionally
conserved genes included integrin members (e.g., ITGAs,
ITGBs) and intracellular signal transducers (e.g., CD47, GAB2,
CIB1). Among the 7 genes encoding integrins, 6 either were
slightly down-regulated in ESC or had little transcriptional
change, while ITGB5 was at least 1.5-fold up-regulated in
hESC but not in mESC. GAB2 and CD47 were at least 1.5-fold
down-regulated in both human and mouse ESCs. The results
suggest that integrin-mediated signaling is mostly repressed in
ESCs or activated in EBs and fundamental to ESC development
in both human and mouse.
Many functional modules were conserved in expression
pattern but not differentially expressed and thus not disclosed in
previous studies based on differentially expressed genes alone.
A total of 237 biological processes, 102 molecular functions,
and 66 cellular components fell into this category of modules
(Supplementary Table S1a–S1c, denoted by [E] without [A.h]
or [B.h] on the term names). The modules included embryonic
morphogenesis (37 orthologous pairs; r=0.42, p=0.005), gene
silencing (8 orthologs; r=0.67, p=0.035), cell cycle arrest
(17 orthologs; r=0.57, p=0.008), G1/S transition of mitotic cell
cycle (18 orthologs; r=0.62, p=0.003), and aging (8 orthologs;
r=0.70, p=0.026), which are known to be important for ESCs.
Many of the modules in this category, however, bear no overt
relationship to ESC development. Further analysis of these
modules may lead to discovery of new mechanisms critical to
ESC development.
Divergent functional modules
Divergent functional modules included those showing
negative or no correlation in the gene expression pattern
between human and mouse ESCs. Fig. 1b shows expression
patterns of some divergent functional modules important for
ESC development (detailed information for each module on the
figure is given in Supplementary Table S3). Table 2B shows
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ESCs and EBs of human and mouse.
The functional modules with negatively correlated expres-
sion patterns represented extreme cases of divergent modules
(Supplementary Tables S1 and S2 with [F] denoted on term
names). One such module is that involved in cytokine–cytokine
receptor interactions. The 69 human–mouse orthologous genes
examined for this module showed a significant level of negative
correlation in expression pattern across species (r=−0.312,
p<0.005) (Fig. 1B; Supplementary Table S3). The genes CCL7,
PDGFRA, IL1R1, CXCL1, and INHBA were down-regulated
in hESCs but up-regulated in mESCs with at least 1.5-fold
change in both species, while the genes INHBE, CXCL12, and
BMP2 were up-regulated in hESCs but down-regulated in
mESCs with at least 1.5-fold change in both species. Opposite
expression patterns for cytokines in hESCs and mESCs were
also observed in other studies [20]. The negatively correlated
expression pattern of cytokine–cytokine receptor interactions is
suggestive of unique and distinct responses of hESCs and
mESCs to growth factors.
The majority of functional modules we examined, including
biological processes, molecular functions, and cellular compo-
nents defined by GO, and pathways defined by KEGG, showed
no correlation in expression pattern across species (Table 1).
From the nonconserved modules, we identified those signifi-
cantly up- or down-regulated in hESCs and mESCs. The results
are summarized in Table 1 and details are given in
Supplementary Tables S1 and S2 (denoted by either [A] or
[B] without [E] on the term names). As shown in Table 1,
among the 508 nonconserved biological processes (56.2% of
the total examined), 135 processes had genes significantly up-
regulated and 113 processes significantly down-regulated in
hESCs. The up- or down-regulated and nonconserved modules
identified in this study are suggestive of species-specific
mechanisms controlling ESC self-renewal and differentiation.
The LIF pathway was not conserved in expression pattern,
with nonsignificant cross-species correlation (r=−0.256,
p=0.17), but was significantly down-regulated in hESCs
although little changed in mESCs (Fig. 1b; Supplementary
Table S3). This result is consistent with the fact that the LIF
pathway is not essential in human but is critical in mouse for
maintaining ESC pluripotency [57,62,63]. Among the 16 ortho-
logous genes examined for this pathway, LIF was expressed at a
much lower level in hESCs than in mESCs, while IL11, STAT6,
STAT5B, SOCS1, and SOCS2 showed highly different
transcriptional changes between hESCs and mESCs.
Similarly, the FGF pathway was not conserved in expression
pattern, with nonsignificant cross-species correlation (r=
−0.172, p=0.24), but was significantly up-regulated in mESCs
but not in hESCs (Fig. 1; Supplementary Table S3). The pathway
is implicated in rodent ICM development and maintenance of
undifferentiated ES cells in culture [64–66]. Among the 19
orthologous genes examined for this pathway, the MAPK
inhibitors DUSP1, DUSP6, and DUSP9 were highly up-
regulated (over twofold) in mESCs but down-regulated or
unchanged in hESCs, thus were highly divergent in expression.
The repressed expression of these genes in hESCs was alsoobserved by RT-PCR analysis [59]. The results suggest that the
FGF pathway acts differently between human and mouse for
ESC self-renewal.
The nonconserved biological processes cytokine secretion and
hormone biosynthesis were significantly up-regulated in hESCs
but not in mESCs (Supplementary Table S1a). In contrast, the
nonconserved biological processes base-excision repair, cytokin-
esis, and embryonic cleavage were significantly up-regulated in
mESCs but not in hESCs (Supplementary Table S1a). Similarly,
the insulin signaling pathway, being not conserved (r=0.06;
orthologs, 73; p=0.310), was significantly up-regulated in
mESCs but down-regulated in hESCs (Table 2). Analysis of
such functional modules facilitates our understanding of species-
specific mechanisms regulating ESC development.
It should be noted that since the nonconserved modules
identified in this study were based on human–mouse ortholo-
gous genes only, not all species-specific biological mechanisms
involved in ESC development were disclosed. Many other
species-specific regulations should be present and activated by
nonhomologous genes in human or mouse ESCs.
Conserved and divergent transcription factors and growth
factors
We examined expression patterns of 304 human–mouse
orthologous genes that show transcription factor activity.
Globally, the transcription factors presented a relatively low
yet highly significant level of cross-species correlation in
expression pattern (r=0.378, p<10−11), suggesting the
presence of conserved core regulatory network in ESCs.
Specifically, 199 of the transcription factors were conserved
by showing up- or down-regulation in the same direction
between hESCs and mESCs, of which 48 genes had at least
1.5-fold transcriptional change upon ESC differentiation in
both species. The remaining 105 transcription factors were
divergent, showing up- or down-regulation in opposite
directions between hESCs and mESCs, of which 9 genes
exhibited at least 1.5-fold transcriptional change upon
differentiation in either or both species. Table 3A lists the
48 transcription factors with conserved expression patterns and
at least 1.5-fold transcriptional change. Also shown in Table
3A are the p values derived from differential expression
analysis of these transcription factors in hESCs and mESCs.
At p<0.05, 18 genes showed significant differential expres-
sion in both hESCs and mESCs. These transcription factors,
with some up-regulated in both hESCs and mESCs and others
down-regulated in both species, are functionally essential and
are likely key elements in the regulatory network controlling
ESC self-renewal and differentiation. Among the 48 transcrip-
tion factors with conserved behavior, 26 are implicated in
development (Table 3A). Some are known to be important for
ESC pluripotency, such as POU5F1, UTF1, MYC, and TP53,
all of which were up-regulated in ESC, and HAND1 and
GATA6, both of which were down-regulated (Table 3A). Table
3B lists the 9 transcription factors that showed divergent
expression patterns with at least 1.5-fold expression change.
These transcription factors may play different or species-
Table 3
Transcriptionally (A) conserved and (B) diverged transcription factors
(A) Conserved
Transcription factor p value in hESC p value in mESC Expression in hESC and mESC Implicated function
MXD4 0.0024 0.0175 Down Cell proliferation
MYC 0.0555 0.0178 Up Cell proliferation
MYST2 0.0009 0.0062 Up Cell proliferation
TP53 0.0204 0.0008 Up Cell proliferation
ARNT2 0.1231 0.0302 Down Development
EVX1 0.2256 0.0112 Down Development
GATA3 0.0150 0.0426 Down Development
GATA6 0.0017 0.0561 Down Development
HAND1 0.0033 0.0329 Down Development
HEY1 0.0032 0.0118 Down Development
HLX1 0.0588 0.0008 Down Development
HOXB5 0.0014 0.0012 Down Development
HOXB6 0.0043 0.0049 Down Development
HOXB9 0.0578 0.0050 Down Development
MAFB 0.0802 0.1325 Down Development
MEF2C 0.0209 0.0551 Down Development
MSX1 0.0030 0.0384 Down Development
MSX2 0.0050 0.0933 Down Development
PITX1 0.0121 0.0234 Down Development
PITX2 0.0054 0.1141 Down Development
RAX 0.0252 0.0004 Down Development
SIX3 0.2344 0.0487 Down Development
SIX5 0.0985 0.0163 Down Development
SOX10 0.1450 0.0121 Down Development
SOX11 0.2070 0.2287 Down Development
TCF21 0.1014 0.0078 Down Development
ZIC1 0.1209 0.3692 Down Development
ZHX1 0.0013 0.0361 Down Development
TGIF 0.0143 0.0128 Up Development
POU5F1 0.0070 0.0328 Up Development
ATBF1 0.0112 0.0086 Down Other
CREB3L1 0.0644 0.1096 Down Other
DSIPI 0.0423 0.1123 Down Other
FOXA1 0.0273 0.0236 Down Other
FOXF1 0.1172 0.0690 Down Other
ISL1 0.0480 0.0877 Down Other
NR2F1 0.1048 0.1984 Down Other
SOX18 0.1016 0.0574 Down Other
SOX7 0.0908 0.0705 Down Other
SPI1 0.1408 0.0076 Down Other
ZFHX4 0.0456 0.0730 Down Other
ZNF42 0.3586 0.0206 Down Other
MYB 0.0176 0.0600 Up Other
MYCN 0.0032 0.0125 Up Other
NFYB 0.0017 0.0132 Up Other
POLR3K 0.0109 0.0519 Up Other
POU2F1 0.0005 0.0870 Up Other
UTF1 0.1303 0.0088 Up Other
(B) Diverged
Transcription factor p value in hESC p value in mESC Expression in hESC Expression in mESC Implicated function
CBFA2T2 0.0619 0.0195 Down Up Cell proliferation
GTF2H1 0.0295 0.0076 Down Up Cell proliferation
IRF1 0.0487 0.0778 Down Up Cell proliferation
STAT5B 0.0030 0.0043 Up Down Signal transduction
STAT6 0.2758 0.0078 No change Up Signal transduction
CEBPB 0.2703 0.0162 No change Up Other
ZNF277 0.2153 0.0318 No change Up Other
TPBG 0.0576 0.0237 Down Up Other
FOXA2 0.1128 0.0786 Up Down Other
The transcription factors that showed at least 1.5-fold up- or down-regulation in the same direction (conserved) or opposite directions (diverged) between human and
mouse ES cells. The p values represent the significance of differential expression in hESCs or mESCs.
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members of important signaling pathways: STAT6 (no
significant change in hESCs, up in mESCs) and STAT5B
(up in hESCs, down in mESCs) are members of the JAK–
STAT pathway involved in LIF signaling; CEBPB (no
significant change in hESCs, up in mESCs) is involved in
IL6 signaling.
Similarly, growth factors overall also showed a conserved
expression pattern between hESCs and mESCs (r=0.375,
p<0.01). Sixty-one orthologous growth factors were examined
in this study. Twenty-one of the growth factors exhibited
negative correlation in expression pattern across species, with 8
of them showing at least 1.5-fold transcriptional change (Table
4B). The patterns of the remaining 40 growth factors were
conserved, with 10 factors showing at least 1.5-fold transcrip-
tional change upon differentiation in both species (Table 4A).
Among the 10 growth factors, 7 are known to be involved in
development and morphogenesis. BMP4, BMP5 (both down-
regulated in ESCs), and GDF3 (up-regulated in ESCs) are
critical members of the BMP signaling pathway. LEFTB and
TDGF1 (both up-regulated in ESCs) participate in Nodal
signaling. Six of the 10 growth factors showed significant
differential expression in both hESCs and mESCs (p<0.05,
Table 4A), including BMP5, GDF3, TDGF1, LEFTB, SCGF,
and FBS1.
Many of the conserved transcription factors and growth
factors show no obvious relationship with ESC development
(Tables 3 and 4). These factors provide a basis for a new
hypothesis about mechanisms underlying ESC development.
Further studies on these genes using RT-PCR, mutation andTable 4
Transcriptionally (A) conserved and (B) diverged growth factors
(A) Conserved
Growth factor hESC p value mESC p value Expressio
SCGF 0.0133 0.0468 Down
BMP4 0.0146 0.0600 Down
BMP5 0.0067 0.0080 Down
IGF2 0.0003 0.0563 Down
MDK 0.0116 0.1218 Down
GDF3 0.0039 0.0169 Up
LEFTB 0.0089 0.0463 Up
TDGF1 0.0021 0.0214 Up
MST1 0.0543 0.0655 Down
FBS1 0.0424 0.0233 Down
(B) Diverged
Growth factor hESC p value mESC p value Expressio
AREG 0.0805 0.2423 Down
CXCL12 0.0417 0.0188 Up
BMP2 0.0783 0.0231 Up
FGF13 0.0212 0.0067 Up
DTR 0.0573 0.1424 Down
INHBA 0.3262 0.0837 No chang
S100A6 0.0443 0.0243 Down
INHBE 0.2185 0.0598 No chang
The growth factors that showed at least 1.5-fold up- or down-regulation in the same d
ES cells. The p values represent the significance of differential expression in hESCsknockout, or computational analysis of pathway dynamics will
help confirm their possible roles in ESC development.
Transcription factors, growth factors and their receptors, and
other intermediate signal transducers form signal transduction
pathways that control the transition and integration of
environmental stimuli and help to determine the fate of ESCs.
Table 2 lists signaling pathways with information on transcrip-
tional changes in hESCs and mESCs and cross-species
conservation, illustrating conserved and divergent mechanisms
regulating ESC development.
Functional profiling of embryonal carcinoma stem cells
To explore “stemness” properties further, we examined
common and different functional features between hESCs and
NTera2 cells. NTera2 is a human embryonal carcinoma stem
cell (hECC) line with less differentiation potential than hESCs.
Supplementary Fig. S1 shows cultured NTera2 cells in the
undifferentiated and differentiated states. From the determined
expression profiles, 2818 up-regulated and 2924 down-
regulated genes were identified (FDR<0.05), listed in Supple-
mentary Table S4. The up-regulated genes in undifferentiated
NTera2 cells included markers characteristic of undifferentiated
hESCs such as POUT5F1, TDGF1, DNMT3B, CD24, LIN28,
CD9, PUM1, PUM2, GJA1, and TERF1. The down-regulated
genes included HAND1, IGF2, and other markers known to
be involved in differentiation. The enriched GO and KEGG
categories for the up- and down-regulated genes are shown in
Supplementary Tables S1 and S2 (denoted with [C] and [D],
respectively, on the term names).n in ESC Implicated function
Cell proliferation
Development/morphogenesis
Development/morphogenesis
Development/morphogenesis
Development/morphogenesis
Development/morphogenesis
Development/morphogenesis
Development/morphogenesis
Other
Other
n in hESC Expression in mESC Implicated function
No change Cell–cell signaling
Down Cell–cell signaling
Down Development
Down Development
No change Development
e Up Development
Up Development
e Down Other
irection (conserved) or opposite directions (diverged) between human and mouse
or mESCs.
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enriched in the up-regulated genes. Among them, 124
processes (i.e., 52.1% of the total) were shared with the 229
biological processes that were up-regulated in hESCs. In the
shared 124 processes, 63 were conserved in expression pattern
between hESCs and mESCs (Supplementary Table S1a).
There were 98 biological processes that were enriched in the
set of down-regulated genes. Among them, 11 processes (i.e.,
11.2% of the total) were shared with the 68 down-regulated
processes of hESCs (Supplementary Table S1). Therefore,
more biological processes are in common between hESCs and
NTera2 cells in the undifferentiated states (as expected) than
in the differentiated state. A similar pattern was also observed
with the GO-defined molecular functions and cellular
components and the KEGG-defined pathways (Supplementary
Tables S1 and S2). The results suggest that hESCs and hECCs
are more similar in mechanisms activated for self-renewal, but
less similar in mechanisms activated for differentiation (or
suppressed for maintaining self-renewal). This observation
emphasizes the fact that while hESCs and hECCs share many
characteristics of pluripotency and express similar “stemness”
markers, the two stem cell types differ in their differentiation
potential. While hESCs can differentiate into cells forming
mesoderm, endoderm, and ectoderm, NTera2 cells differenti-
ate mainly into neuroectoderm cells [26,67,68]. It was
observed that biological processes related to embryonic
development were significantly down-regulated and thus
repressed in hESCs, but not down-regulated in NTera2
undifferentiated cells. Moreover, about 30% of the down-
regulated biological processes in hESCs were related to
development, whereas only ∼7% of the down-regulated
processes in undifferentiated NTera2 cells were related to
development (Supplementary Table S1a). The results highlight
the fact that NTera2 cells possess less differentiation potential
than ESCs.
The functional modules that are common between hESCs
and hECCs in the up-regulated genes and are conserved in
expression pattern between hESCs and mESCs represent core
molecular mechanisms that are activated for self-renewal in
stem cells of different sources. To achieve indefinite self-
renewal and maintain the pluripotent state, stem cells are primed
for rapid and accurate DNA replication by shortening the cell
cycle, relaxing G1/S checkpoints, strengthening DNA repair,
enhancing the response to unfolded proteins, and activating
apoptosis. In addition, metabolic processes related to nucleotide
synthesis, DNA replication, and DNA packaging are also
activated [40]. All these biological processes or related
pathways were conserved in expression patterns between
hESCs and mESCs and common between hESCs and hECCs
(Supplementary Tables S1 and S2, denoted by [E], [A], and [C]
at the term names; Figs. 1A and 2). In addition, the telomere
maintenance and aging-related processes were also conserved
and up-regulated in both hESCs and hECCs (Supplementary
Table S1a), in keeping with the fact that stem cells have a longer
half-life than somatic cells.
NTera2 cells are aneuploid; it is possible that overrepresen-
tation of some genes in the genome may lead to theiroverexpression in NTera2 cells. This “gene loading” effect on
transcriptional pattern of NTera2 cells has not yet been fully
explored in previous studies [69,70]. There are some practical
difficulties in examining the correlation between gene expres-
sion levels and the cytogenetic profiles in NTera2 cells. First,
the karyotype of NTera2 is not very well defined yet. Plaia et al.
[71] showed that 48% of NTera2 cells had 63 chromosomes,
24% had 62 chromosomes, and the rest had other numbers of
chromosomes. Second, some of the chromosomes are not
normal [71]. There are 12 marker chromosomes, including der
(9)t(1;9) (q25;q34.3), del(1) (q25), der(13)t(11;13) (q13;q34),
t(Xq1q), and 8 others. At least 2 markers are found only in some
cells. Therefore, a well-defined copy number of each gene in
NTera2 cells is not yet available for an analysis [71]. The impact
of “gene loading” on the expression analysis result of this study
remains to be determined.
Discussion
In this study, we systematically surveyed a large set of
functional modules and examined all transcription factors and
growth factors for cross-species functional profiling of ESCs.
We examined global transcriptional trends derived from all
expressed genes, instead of differentially expressed genes
alone, for each functional module and obtained a great
discriminating power in the functional profiling. Despite the
fact that only human–mouse orthologous genes were used in
this study, a number of functional modules were identified that
were transcriptionally conserved and thus predicted to be
essential for ESC development. This study thus generated a
global and comprehensive functional portrait of ESCs, featured
by conserved and divergent landscapes emphasizing funda-
mental and species-specific mechanisms that regulate ESC
development. The data and analyses resulting from this study
provide a framework for new hypotheses and research
directions and a public resource for functional genomics of
ESCs.
We demonstrate that cross-species correlation of gene
expression patterns is a powerful predictor of functional
mechanisms that are fundamental for ESC development.
Much of our current knowledge of ESC-relevant pathways
and networks is supported or reaffirmed by this correlation
analysis, justifying the prediction. In hESCs, among the 407 up-
or down-regulated biological processes, 159 (27% of the total)
were identified to be conserved in expression pattern and thus
deemed to be functionally essential. In mESCs, a similar portion
of conserved modules was identified from up- or down-
regulated biological processes. Our studies thus provide a
focused list of important pathways or functional modules for in-
depth investigation. Moreover, we demonstrate that functional
modules, such as BMP/TDGF-β and Wnt pathways, may be a
mosaic of submodules showing different evolutionary patterns.
Cross-species correlation of gene expression allows for
prediction of conserved and thus core functional submodules
present within a pathway, facilitating the examination. Yet,
many of the conserved biological processes, pathways, and
transcription or growth factors identified in this study bear no
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conserved modules are not recognized from previous fold-
change-based analyses, since only a small portion of genes in
the modules showed significant transcriptional changes upon
ESC differentiation. Further examination of these functional
modules may lead to discovery of new mechanisms critical for
ESC pluripotency.
While conserved functional modules represent biological
mechanisms that are fundamental, the nonconserved modules
identified by this study are suggestive of species-specific
regulation in ESC development. The nonconserved nature of
functional modules could be due to several factors: (1)
functions carried out by these modules are redundant so that
different organisms may use different modules to carry out
the same function; (2) there exist duplicated genes in a
module, and different sets of genes of the module are
activated or repressed to achieve the same effect in different
organisms; (3) not all orthologous genes in a module are
included in calculating the correlation of expression pattern.
More hypotheses are possible based on the profiled ESC
functional portrait. Analysis driven by these or other
hypotheses on the nonconserved modules would shed light
on our understanding of species-specific mechanisms regulat-
ing ESC development.
A relatively small portion of functional modules showed
significant negative correlation (Table 1), indicating that a
very few modules carry out completely opposite activities in
hESC and mESC during their differentiation. The result
suggests that human and mouse in general share many similar
mechanisms that control ESC development. Nevertheless,
there may exist more negatively correlated modules that are
not annotated by GO or KEGG and thus not captured by our
analysis.
The observed conservation and variation of functional
modules at the gene transcriptional level are consistent with
their evolutionary patterns at the gene structural level.
Consistent with the conserved expression pattern of the Nodal
pathway (Fig. 1), Nodal and TDFG1 of the pathway are highly
conserved in gene and promoter structure between human and
mouse [19], suggestive of conserved activation mechanisms of
the pathway. Consistent with the divergent expression pattern of
the FGF pathway (Fig. 1), FGF4 of the pathway shows
sequence divergence in the Sox2–Oct3/4 cobinding site of an
enhancer [19]. The Sox2–Oct3/4 cobinding site is critical to the
self-renewal of mESCs; the sequence divergence in the
cobinding site makes the transcription of the gene less effective
in humans than in rodents [65]. Furthermore, consistent with the
divergent expression pattern of the LIF pathway (Fig. 1), LIFR
and IL6ST (GP130) of the pathway are highly divergent in gene
and promoter structure between human and mouse [19],
highlighting the fact that LIF signaling is required in mouse
but is not essential in human for maintaining ESC pluripotency
[57,62,63]. Reportedly, the collaboration between LIF signaling
and the BMP/TGF-β pathway helps to sustain pluripotency in
mESCs [57]. Since the LIF pathway is diverged and not
fundamental, the collaboration is likely not fundamental in
human or other species either. Although the BMP/TGF-βpathway is transcriptionally conserved (Fig. 1), BMP4 has
different effects on mouse and human ESCs: it blocks ESC
differentiation along the neuroectoderm default pathway in
mouse [57], while it induces trophectoderm differentiation of
ESCs in human [72]. It is possible that the different impacts of
BMP signaling on ESC development in human and mouse are
due to the diverged LIF signaling that interacts with BMP
signaling.
We demonstrate that while pluripotency as an essential
function in multicellular organisms is conserved through
evolution, the mechanisms primed for differentiation are less
conserved and contribute in a larger extent to the differences
among stem cells derived from different tissues or species.
Between different stem cell types (e.g., hESCs and hECCs),
there are more similarities in the mechanisms activated for
self-renewal than in those activated for differentiation. Within
the same stem cell type, more up-regulated modules are
conserved than down-regulated modules. Specifically, in
hESCs, 43.7% up-regulated biological processes (105 of
240) were conserved, while 32.3% down-regulated biological
processes (54 of 167) were conserved (Supplementary Table
S1a). In mESCs, 37.2% up-regulated biological processes
were conserved, while 19.5% down-regulated biological
processes were conserved (Supplementary Table S1a).
Because biological mechanisms primed for differentiation are
evolutionarily less conserved, ESC lines derived from different
species (e.g., hESC, mESC) or isolated from different tissues
(e.g., ESCs, ECCs) likely adapt distinctive mechanisms
activated for differentiation.
It would be interesting to compare the conserved modules
detected in ESCs with those detected in other types of stem cells
or even somatic cells. Such comparisons would help us further
distinguish those processes critical for stem cell self-renewal
from those governing differentiation and those underlying
housekeeping functions.
In summary, this study described conserved and divergent
functional landscapes of ESCs, profiled by global transcrip-
tional trend across species in addition to differentially expressed
genes. The conserved modules on the landscape represent core
biological networks or mechanisms fundamental to ESC
development, while the divergent modules are suggestive of
species-specific regulation. The cross-species correlation of
gene expression pattern is a powerful predictor of important
biological pathways, as well as functional cores within a
pathway. The examination of hECC NEera2 revealed a
functional basis of different differentiation potentials yet similar
pluripotency in different kinds of stem cells. While pluripotency
is conserved through evolution, the mechanisms primed for
differentiation are less conserved and contribute to a larger
extent to the differences among stem cells derived from
different tissues or species. The functional portrait of ESCs
profiled by this study provides a basis for defining the
“stemness” property in terms of evolutionary conservation
and variation and a framework for new hypotheses and research
directions on ESCs. The findings and methods reported in this
investigation are significant in advancing our understanding of
stem cell biology.
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Human ESC culture
The human ESC lines used in this study included BG01 (46 chromosomes
with XY), BG01V (49 chromosomes with XXY, +12, +17), BG02 (46
chromosomes with XY), and BG03 (46 chromosomes with XX), which are
registered with the NIH (http://stemcells.nih.gov/index.asp). Each cell line
was used as one sample and another sample was prepared by pooling different
cell lines. Human ESCs were primarily cultured on mitotically inactivated
mouse embryonic fibroblasts (MEF) or HS27 human fibroblasts (HS27,
ATCC) in DMEM/F12-Glutamax supplemented with 20% Knockout Serum
Replacement, 0.1 mM nonessential amino acids, 100 μM β-mercaptoethanol,
50 μg/ml Pen-Strep (all from Invitrogen), and 4 ng/ml human recombinant
basic fibroblast growth factor (PeproTech). Cultures were expanded by
passaging clumps of ∼10–100 cells. To remove contaminating feeder cells,
hESCs were replaced on an extracellular matrix of Matrigel (BD Biosciences)
or fibronectin (Sigma) at least three times before RNA extraction. During
feeder-free culture, human ESC medium was preconditioned with inactivated
MEFs [25] for 1 day. Supplementary Fig. S1 shows the cultured human
ES cells. A detailed manual of the human ES cells described here is
available online at the NIH stem cell Web site (http://stemcells.nih.gov/
index.asp).
Differentiation of ESCs as embryoid bodies
For embryoid body formation, hESCs were harvested as clumps with
collagenase (1 mg/ml; Invitrogen) and resuspended in DMEM/F12
supplemented with 15% FCS, 5% KSR, 2 mM L-glutamine, 50 μg/ml
Pen-Strep, 0.1 mM β-mercaptoethanol, and 0.1 mM nonessential amino
acids. Medium was changed every other day and RNA was extracted at day
14 after EB formation. Supplementary Fig. S1 shows the generated embryoid
bodies.
NTera2 cell line
The NTera2 cell line was purchased from American Type Culture
Collection (ATCC) and cultured in parallel with hESCs using protocols
described in [26]. Briefly, NTera2 were cultured as a monolayer on
standard tissue culture plasticware in DMEM/F12 supplemented with 10%
FCS and 2 mM L-glutamine. Cells were passaged every 3 to 5 days upon
confluence. Differentiation of NTera2 cells was induced by coculture with
the mouse stromal cell line PA6 or with mitotically inactivated PA6 cells
[26]. Two samples of differentiated NTera2 cells were prepared either with
mitotically inactive or with active PA6 cells for this study. One sample was
induced by the mouse stromal cell line PA6, another with mitotically
inactivate PA6 cells. Since their expression patterns showed strong
correlation (r=0.987), they were used as replicates in the analysis.
Supplementary Fig. S1 shows the cultured undifferentiated and differentiated
NTera2 cells.
RNA extraction, BeadArray preparation, and data processing
RNA was extracted using a standard Trizol (Invitrogen) method. The
Illumina HumanRef-8 BeadArray was used in this study, which contained
23,584 probes, representing 20,692 genes recognized by RefSeq (http://ncbi.
nih.gov/RefSeq/). Each gene or transcript was represented on the BeadArray
by 3–10 oligonucleotides, each 50 bases long. Arrays were scanned with the
Illumina BeadArray Reader confocal scanner according to the manufacturer’s
instructions. The Illumina BeadStudio software was used to perform
background correction and generate absolute expression estimates. Details of
the RNA amplification, labeling, and hybridization steps are available from
www.Illumina.com. Low expression values (<50) were substituted with 50. If
expression values of a gene were all less than or equal to 50, it was removed
from further analysis. The mean intensity of an individual probe was calculated
across all arrays, normalized by the quantile method [27], and the log2 ratio of
each value to this mean was calculated. When several probes corresponded tothe same gene (i.e., if different probes had the same gene symbol or GenBank
ID), a single probe was kept for the analysis.
Cross-species comparison of gene expression pattern
The mESC dataset used in this study was obtained from the GEO database
(GSE2375) and contained expression profiles of the R1 cell line and
differentiated EB counterpart. To compare gene expression patterns between
different organisms, we implemented a method similar to that previously
described [10]. The list of human and mouse orthologous genes was obtained
from the Affymetrix human–mouse orthologs link and the Inparanoid database
(http://inparanoid.cgb.ki.se/). From the hESC and mESC datasets, we retrieved
7041 human–mouse orthologous gene pairs. After removing transcripts with
low signal levels, we obtained 5459 pairs of orthologous genes for our analysis.
Orthologous gene pairs were grouped by their corresponding GO categories. For
each group of orthologous genes, evolutionary conservation of expression
pattern was assessed by the correlation of the log-transformed (base 2) relative
change in expression (condition 1 divided by condition 2) of the orthologous
genes under different conditions. The probability of obtaining a Pearson
correlation (r) from a group of n pairs of orthologous genes was computed by
treating
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðn 2Þp  rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð1 r2Þp as coming from a t distribution with n−2 degrees of
freedom [28].
Identification of differentially expressed genes and principle
component analysis
Differentially expressed genes between ESCs and EBs were identified by
the paired t test. Differentially expressed genes between undifferentiated
and differentiated NTera2 cells were identified using the local pooled error
algorithm [29], which is particularly useful for dealing with data of small sample
sizes. The analyses were performed using bioconductor (www.bioconductor.org).
Significantly enriched GO terms
The Fisher exact test was conducted to calculate the hypergeometric
probability of observing a GO term as enriched in each group of genes.
Specifically, the probability p that a GO term is significantly enriched in a group
of genes was calculated as p ¼ 1
Pk1
i0
A
i
 
G A
n 1
 
G
n
  where k is the numberof genes in the group, G is the total number of genes, n is the number of genes in
the group with a given GO term, and A is the total number of genes with a given
GO term.
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